LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - IN8bio (NASDAQ: INAB)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ INAB IN8bio
Epperly Corinne / director
12/19/2024
Buy
$0.24
37,655
$9K
37,655
NASDAQ INAB IN8bio
Graff Jeremy R. / director
12/19/2024
Buy
$0.24
47,697
$11K
47,697
NASDAQ INAB IN8bio
Greenwood Luba / director
12/19/2024
Buy
$0.24
39,449
$9K
39,449
NASDAQ INAB IN8bio
FAIRBAIRN EMILY / director
12/19/2024
Buy
$0.24
31,559
$8K
31,559
NASDAQ INAB IN8bio
Whitfill Travis / director
12/19/2024
Buy
$0.24
42,676
$10K
42,676
NASDAQ INAB IN8bio
Brandt Peter C. / director
12/19/2024
Buy
$0.24
49,490
$12K
49,490
NASDAQ INAB IN8bio
Roemer Alan S. / director
12/19/2024
Buy
$0.24
93,242
$22K
93,242
NASDAQ INAB IN8bio
McCall Patrick / officer: CHIEF FINANCIAL OFFICER
12/19/2024
Buy
$0.24
290,085
$70K
290,085
NASDAQ INAB IN8bio
Lamb Lawrence / officer: EVP and CSO
12/19/2024
Buy
$0.24
286,899
$69K
286,899
NASDAQ INAB IN8bio
Rochlin Kate / officer: Chief Operating Officer
12/19/2024
Buy
$0.24
302,839
$73K
302,839
NASDAQ INAB IN8bio
Ho William Tai-Wei / director, 10 percent owner, officer: PRESIDENT AND CEO
12/19/2024
Buy
$0.24
1.19M
$285K
1.19M